Fetal Surgery for Myelomeningocele

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Myelomeningocele (MMC) is a congenital neural tube defect that occurs in approximately 1 in 2900 live births in the United States. It is a devastating disability with significant morbidity and mortality within the first few decades of life. MMC was the first nonlethal disease to be considered and studied for fetal surgery and is now the most common open fetal surgery performed. The recently completed MOMS randomized controlled trial has shown that fetal repair for MMC can improve hydrocephalus and hindbrain herniation, can reduce the need for vetriculoperitoneal shunting, and may improve distal neurologic function in some patients.

Original languageEnglish (US)
Pages (from-to)279-288
Number of pages10
JournalClinics in Perinatology
Issue number2
StatePublished - Jun 2012


  • Fetal surgery
  • Hydrocephalus
  • Myelomeningocele
  • Neural tube defect
  • Shunt
  • Spina bifida
  • Ventriculomegaly

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Fetal Surgery for Myelomeningocele'. Together they form a unique fingerprint.

Cite this